Investigation of Respiratory Muscle Strength, Respiratory Muscle Endurance and Muscle Oxygenation in Patients With Rheumatoid Arthritis

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The aim of this study is to investigate respiratory muscle strength, respiratory muscle endurance, muscle oxygenation, upper extremity and lower extremity exercise capacity in rheumatoid arthritis patients compared with healthy individuals.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• Patients diagnosed with rheumatoid arthritis,

• The ages of 18-65 years,

• Volunteer to participate in the study will be included in the study.

• The ages of 18-65 years,

• Volunteer to participate in the study will be included in the study.

Locations
Other Locations
Turkey
Kırşehir Ahi Evran University, Physical Therapy and Rehabilitation Center, Cardiopulmonary Unit
RECRUITING
Kırşehir
Contact Information
Primary
Başak KAVALCI KOL, PhD
basak.kavalci@ahievran.edu.tr
+903862802317
Time Frame
Start Date: 2025-01-25
Estimated Completion Date: 2027-01-25
Participants
Target number of participants: 68
Treatments
Rheumatoid Arthritis Group
Rheumatoid arthritis patients who are followed up in the Rheumatology Outpatient Clinic of the Department of Physical Medicine and Rehabilitation (diagnosed according to American College of Rheumatology/European Alliance of Associations for Rheumatology ACR/EULAR 2022 diagnostic criteria), aged between 18-65 years, and have a Disease Activity Score (DAS) -28 score below 2.6 in disease remission will be included.
Control Group
As a control group, healthy individuals between the ages of 18-65, who are similar to the patients in terms of age and gender, without any disease, will be included in the study. Healthy individuals in the control group will be selected from volunteer colleagues, school friends, family and residential areas of the researchers to participate in the study.
Related Therapeutic Areas
Sponsors
Leads: Kirsehir Ahi Evran Universitesi

This content was sourced from clinicaltrials.gov